OncoPep

North Andover, United States

OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.

$11.0M raised

Dec 2021

Series D

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OncoPep raised?

OncoPep has raised $11.0M in total funding. The most recent round was Series D. The last funding was announced in December 2021.

Who are OncoPep's investors?

OncoPep's investors include Blood Cancer United, Inc., Crystal Bioscience, Kukje Pharma, Tera Science.

Where is OncoPep headquartered?

OncoPep is headquartered in North Andover, United States.

What does OncoPep do?

OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.

What stage is OncoPep at?

OncoPep is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 10, 2021.

MLA

"OncoPep — Funding & Investors." VCBacked, December 10, 2021, https://www.vcbacked.co/company/oncopep. Accessed July 3, 2026.

APA

VCBacked. (2021). OncoPep — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/oncopep

Wikipedia (cite web)

{{cite web |title=OncoPep — Funding & Investors |url=https://www.vcbacked.co/company/oncopep |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 10, 2021.